Chemotherapy, immunosuppression, and anesthesia

Ben Chortkoff; David Stenehjem

doi:10.1016/B978-0-323-48110-6.00038-7

Chemotherapy, immunosuppression, and anesthesia

Ben Chortkoff, David Stenehjem

Duluth Pharmacy Program

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

In the United States, nearly 5% of the population has or has had cancer. Anesthetists frequently encounter patients in all stages of cancer and cancer treatment. This chapter highlights the short term and long term end-organ effects of common chemotherapeutics relevant to the anesthetist and reviews current concepts about how anesthetics may impact cancer and cancer survival.

Original language	English (US)
Title of host publication	Pharmacology and Physiology for Anesthesia
Subtitle of host publication	Foundations and Clinical Application
Publisher	Elsevier
Pages	753-768
Number of pages	16
ISBN (Electronic)	9780323481106
ISBN (Print)	9780323776981
DOIs	https://doi.org/10.1016/B978-0-323-48110-6.00038-7
State	Published - Jan 1 2018

Keywords

Angiogenesis
Cardiotoxicity
Immunotherapy
Malignancy
Metastasis
Monoclonal antibodies
Oxygen free radicals
Pulmonary fibrosis

Access

10.1016/B978-0-323-48110-6.00038-7

Fingerprint Dive into the research topics of 'Chemotherapy, immunosuppression, and anesthesia'. Together they form a unique fingerprint.

Cite this

Chortkoff, B., & Stenehjem, D. (2018). Chemotherapy, immunosuppression, and anesthesia. In Pharmacology and Physiology for Anesthesia: Foundations and Clinical Application (pp. 753-768). Elsevier. https://doi.org/10.1016/B978-0-323-48110-6.00038-7

@inbook{aa6eb821252d4c18a381c1760b0e10e4,

title = "Chemotherapy, immunosuppression, and anesthesia",

abstract = "In the United States, nearly 5% of the population has or has had cancer. Anesthetists frequently encounter patients in all stages of cancer and cancer treatment. This chapter highlights the short term and long term end-organ effects of common chemotherapeutics relevant to the anesthetist and reviews current concepts about how anesthetics may impact cancer and cancer survival.",

keywords = "Angiogenesis, Cardiotoxicity, Immunotherapy, Malignancy, Metastasis, Monoclonal antibodies, Oxygen free radicals, Pulmonary fibrosis",

author = "Ben Chortkoff and David Stenehjem",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-48110-6.00038-7",

language = "English (US)",

isbn = "9780323776981",

pages = "753--768",

booktitle = "Pharmacology and Physiology for Anesthesia",

publisher = "Elsevier",

}

TY - CHAP

T1 - Chemotherapy, immunosuppression, and anesthesia

AU - Chortkoff, Ben

AU - Stenehjem, David

PY - 2018/1/1

Y1 - 2018/1/1

N2 - In the United States, nearly 5% of the population has or has had cancer. Anesthetists frequently encounter patients in all stages of cancer and cancer treatment. This chapter highlights the short term and long term end-organ effects of common chemotherapeutics relevant to the anesthetist and reviews current concepts about how anesthetics may impact cancer and cancer survival.

AB - In the United States, nearly 5% of the population has or has had cancer. Anesthetists frequently encounter patients in all stages of cancer and cancer treatment. This chapter highlights the short term and long term end-organ effects of common chemotherapeutics relevant to the anesthetist and reviews current concepts about how anesthetics may impact cancer and cancer survival.

KW - Angiogenesis

KW - Cardiotoxicity

KW - Immunotherapy

KW - Malignancy

KW - Metastasis

KW - Monoclonal antibodies

KW - Oxygen free radicals

KW - Pulmonary fibrosis

UR - http://www.scopus.com/inward/record.url?scp=85081888630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081888630&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-48110-6.00038-7

DO - 10.1016/B978-0-323-48110-6.00038-7

M3 - Chapter

AN - SCOPUS:85081888630

SN - 9780323776981

SP - 753

EP - 768

BT - Pharmacology and Physiology for Anesthesia

PB - Elsevier

ER -